JMP Securities starts Astria Therapeutics stock at Market Outperform
JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...
JMP Securities raises Pharvaris stock target to $55
Wolleben's updated price target is a reflection of a revised revenue forecast for Pharvaris's prophylactic treatment, ...
Uber has to use M&A to acquire AV technology, says JMP Securities
With Tesla (TSLA) planning to launch unsupervised full self-driving as a paid service in Austin in June and in California by year end while ...
KalVista initiated with an Outperform at JMP Securities
JMP Securities initiated coverage of KalVista (KALV) with an Outperform rating and $19 price target KalVista is developing sebetralstat, a ...